These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 31411928)

  • 1. Correction to:
    Cancer Biother Radiopharm; 2019 Aug; 34(6):417. PubMed ID: 31411928
    [No Abstract]   [Full Text] [Related]  

  • 2. Correction to: Cancer Biother Radiopharm 2014;29(8):303-309. DOI: 10.1089/cbr.2014.1653 and Cancer Biother Radiopharm 2014;29(10):451-456. DOI: 10.1089/cbr.2014.1698.
    Cancer Biother Radiopharm; 2018 Oct; 33(8):363. PubMed ID: 31329732
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Cancer Biother Radiopharm; 2020 Oct; 35(8):627. PubMed ID: 32985893
    [No Abstract]   [Full Text] [Related]  

  • 4. Correction to:
    Cancer Biother Radiopharm; 2018 Oct; 33(8):361. PubMed ID: 31329730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correction to:
    Cancer Biother Radiopharm; 2018 Oct; 33(8):362. PubMed ID: 31329731
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Cancer Biother Radiopharm; 2020 Oct; 35(8):628. PubMed ID: 33064575
    [No Abstract]   [Full Text] [Related]  

  • 7. Correction to: Cancer Biother Radiopharm 2017;32(3):101-110.
    Cancer Biother Radiopharm; 2017 May; 32(4):147. PubMed ID: 28475357
    [No Abstract]   [Full Text] [Related]  

  • 8.
    Cancer Biother Radiopharm; 2022 Mar; 37(2):159. PubMed ID: 35294306
    [No Abstract]   [Full Text] [Related]  

  • 9. Synthesis and application of [18F]FDG-maleimidehexyloxime ([18F]FDG-MHO): a [18F]FDG-based prosthetic group for the chemoselective 18F-labeling of peptides and proteins.
    Wuest F; Berndt M; Bergmann R; van den Hoff J; Pietzsch J
    Bioconjug Chem; 2008 Jun; 19(6):1202-10. PubMed ID: 18481886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The nonpeptidyl caspase binding radioligand (S)-1-(4-(2-[18F]Fluoroethoxy)-benzyl)-5-[1-(2-methoxymethylpyrrolidinyl)sulfonyl]isatin ([18F]CbR) as potential positron emission tomography-compatible apoptosis imaging agent.
    Faust A; Wagner S; Law MP; Hermann S; Schnöckel U; Keul P; Schober O; Schäfers M; Levkau B; Kopka K
    Q J Nucl Med Mol Imaging; 2007 Mar; 51(1):67-73. PubMed ID: 17372575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apoptosis imaging studies in various animal models using radio-iodinated peptide.
    Kwak W; Ha YS; Soni N; Lee W; Park SI; Ahn H; An GI; Kim IS; Lee BH; Yoo J
    Apoptosis; 2015 Jan; 20(1):110-21. PubMed ID: 25430587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of [18F]FDG in radiolabeling reactions using microfluidic technology.
    Bouvet VR; Wuest F
    Lab Chip; 2013 Nov; 13(22):4290-4. PubMed ID: 24056916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo evaluation of the effects of simultaneous inhibition of GLUT-1 and HIF-1α by antisense oligodeoxynucleotides on the radiosensitivity of laryngeal carcinoma using micro 18F-FDG PET/CT.
    Shen LF; Zhao X; Zhou SH; Lu ZJ; Zhao K; Fan J; Zhou ML
    Oncotarget; 2017 May; 8(21):34709-34726. PubMed ID: 28410229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biologic correlates of intratumoral heterogeneity in 18F-FDG distribution with regional expression of glucose transporters and hexokinase-II in experimental tumor.
    Zhao S; Kuge Y; Mochizuki T; Takahashi T; Nakada K; Sato M; Takei T; Tamaki N
    J Nucl Med; 2005 Apr; 46(4):675-82. PubMed ID: 15809491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [18F]Galacto-RGD: synthesis, radiolabeling, metabolic stability, and radiation dose estimates.
    Haubner R; Kuhnast B; Mang C; Weber WA; Kessler H; Wester HJ; Schwaiger M
    Bioconjug Chem; 2004; 15(1):61-9. PubMed ID: 14733584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of head and neck cancer with 18F-FDG PET: a comparison with conventional methods.
    Kresnik E; Mikosch P; Gallowitsch HJ; Kogler D; Wiesser S; Heinisch M; Unterweger O; Raunik W; Kumnig G; Gomez I; Grünbacher G; Lind P
    Eur J Nucl Med; 2001 Jul; 28(7):816-21. PubMed ID: 11504077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [18F-Berberine Derivatives: a Potential Molecular Imaging Agent for Tumor Targeting by PET/CT Tumor].
    Mei X; Wu X; Zhang T; Liang M; Fan C
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2015 Apr; 32(2):460-4. PubMed ID: 26211272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis, 18F-labeling, and in vitro and in vivo studies of bombesin peptides modified with silicon-based building blocks.
    Höhne A; Mu L; Honer M; Schubiger PA; Ametamey SM; Graham K; Stellfeld T; Borkowski S; Berndorff D; Klar U; Voigtmann U; Cyr JE; Friebe M; Dinkelborg L; Srinivasan A
    Bioconjug Chem; 2008 Sep; 19(9):1871-9. PubMed ID: 18754574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiopharmacological evaluation of (18)F-labeled phosphatidylserine-binding peptides for molecular imaging of apoptosis.
    Wuest M; Perreault A; Kapty J; Richter S; Foerster C; Bergman C; Way J; Mercer J; Wuest F
    Nucl Med Biol; 2015 Nov; 42(11):864-74. PubMed ID: 26205076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined 18F-FDG and 11C-methionine PET scans in patients with newly progressive metastatic prostate cancer.
    Nuñez R; Macapinlac HA; Yeung HW; Akhurst T; Cai S; Osman I; Gonen M; Riedel E; Scher HI; Larson SM
    J Nucl Med; 2002 Jan; 43(1):46-55. PubMed ID: 11801702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.